
Resistant bacterial infections kill more than a million people a year. Six species of bacteria cause roughly three in four of those deaths, and resistance to just two families of antibiotics accounts for a similar share. Thousands of the genes that cause this resistance are known; however, they do not all carry the same risk. So how do we tell which ones to worry about? The story of one gene gets us most of the way there.
Two places in one year
In 1989, a laboratory in Munich found, in a patient, E. coli that was destroying cefotaxime, an antibiotic then considered dependable. The next year, laboratories in South America had a similar finding in a different bacterium. The protein doing this destroying was named CTX-M, CTX for cefotaxime and M for Munich. The gene that builds it is blaCTX-M, and this gene is what the rest of this story follows.
Where it came from
Thirteen years after the Munich report, two groups working separately arrived at the same answer about where the gene had come from. One way to uncover the origin of a gene is to build a family tree of the gene and set it beside the family tree of the bacteria carrying it. A gene that has been passed down from parent to offspring shows up in bacteria that are close relatives of its host. blaCTX-M’s nearest matches sat somewhere else: on the chromosome of Kluyvera, the permanent DNA a bacterium passes only to its own descendants. Kluyvera is a bacterium of soil, water and sewage, and not a close relative of E. coli. This is the mismatch researchers watch for: a gene whose history does not line up with the history of its hosts. The blaCTX-M gene in the E. coli had not been inherited. It had been acquired.
How it got out
The vehicle was a piece of DNA called an insertion sequence, in this case one named ISEcp1. An insertion sequence moves itself from one position in the DNA to another. When it moves, it can often take a stretch of neighbouring DNA with it. A gene sitting beside it can be carried out of a chromosome, where it had been passed down quietly from one generation to the next, and dropped into a plasmid, a small circular piece of DNA that bacteria pass to each other. That change of address matters for a resistance gene. A gene on a chromosome typically goes only to the cell’s own descendants. A gene on a plasmid can be handed to a bacterium from an entirely different group.
How it spread
By the late 1990s, CTX-M genes were turning up in hospital bacteria in several countries. Then, in 1999, six patients at a single hospital in New Delhi were found carrying a version that differed from the one already circulating by a single letter substitution. It was the first time anyone had described it. That one change let the protein destroy ceftazidime as well, an antibiotic the earlier version could barely touch. The new variant was called CTX-M-15. It was reported in the United Kingdom by 2003, and it is now the most widespread CTX-M version in the world. It also did not stay confined to hospitals. It has since been found in farm animals, in wildlife, in food and in the environment.
What it costs
The antibiotics CTX-M destroys are not specialist medicines. Cefotaxime, ceftazidime and others like them are beta-lactams, one of the two antibiotic families behind most of the deaths from resistant infections, and they treat everyday illnesses including urinary infections and pneumonia. When they stop working, the next option is usually a carbapenem, an antibiotic that doctors hold back for the hardest cases. Carbapenems are beta-lactams too, and using more of it drives the carbapenem resistance I wrote about earlier in my blog series. CTX-M also rarely travels alone. The plasmids carrying it usually carry other resistance genes too, so treating with one antibiotic can favour bacteria that resist several.
A gene that is acquired rather than inherited. A gene sitting on DNA that can carry it between unrelated bacteria. A gene whose numbers, range and hosts keep growing. A gene that defeats an antibiotic people depend on. These are some of the tell-tale signs of a high-risk antimicrobial resistance gene.
In my next post, I will be sharing some reflections on the World Antimicrobial Resistance (AMR) Awareness Week which runs from 18 to 24 November 2026 under the theme “One Health, one action: Prevent AMR now.”
Photo by Rain Photography